Pilot Study of a New Nicotine Replacement Therapy
Pilot Study on Usage Patterns of a Novel Nicotine Replacement Therapy - A Multi-Center, Open, 3-Week Randomized Low Intervention Study of Two Different Directions for Use in Smokers Motivated to Quit
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Phase 2
Contacts and Locations
Study Locations
-
-
-
Birmingham, United Kingdom, B15 2TT
- Department of Primary Care and General Practice, University of Birmingham
-
London, United Kingdom, E1 2AD
- Tobacco Dependence Research Centre at Barts and The London Queen Mary's School of Medicine and Dentistry
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- 18 years or older male and female cigarette smokers motivated and willing to stop smoking
- female participants of child-bearing potential should use a medically acceptable means of birth control
- evidence of a personally signed and dated informed consent document indicating that the subject has been informed of all pertinent aspects of the study and consents to participate
Exclusion Criteria:
- unstable angina pectoris or myocardial infarction during the previous 3 months
- pregnancy, lactation or intended pregnancy (non-pregnancy will be verified by urine pregnancy test for female participants of child-bearing potential)
- participation in other clinical trials within the previous three months and during study participation
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Active Comparator: 1
Standard NRT user direction
|
Nicotine replacement therapy with Standard NRT user direction
Other Names:
Nicotine replacement therapy with a Novel NRT user direction
Other Names:
|
|
Experimental: 2
Novel NRT user direction
|
Nicotine replacement therapy with Standard NRT user direction
Other Names:
Nicotine replacement therapy with a Novel NRT user direction
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Mean hourly and daily number of doses used
Time Frame: throughout study
|
throughout study
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Mean number of NRT use occasions per day
Time Frame: Week 1, 2, and 3
|
Week 1, 2, and 3
|
|
Ratings of craving/urge to smoke and withdrawal symptoms
Time Frame: Day 1-14, and Day 20
|
Day 1-14, and Day 20
|
|
Self-reported continuous abstinence from smoking, verified by an exhaled CO level of less than 10 ppm
Time Frame: Day 1-21
|
Day 1-21
|
|
Cotinine levels
Time Frame: At baseline and week 3
|
At baseline and week 3
|
|
Product acceptability
Time Frame: At week 3 visit
|
At week 3 visit
|
|
Safety Assessments will consist of monitoring and recording all non-serious Adverse Events and Serious Adverse Events , their frequency, severity, seriousness, and relationship to the investigational product.
Time Frame: throughout duration of the study (+ 30 days for spontaneous SAEs)
|
throughout duration of the study (+ 30 days for spontaneous SAEs)
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Study Director: Elisabeth Kruse, PhD, Global Medical Affairs & Clinical Research, McNeil AB, Sweden
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Estimate)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- NICTDP2010
- 2008-002498-11 (EudraCT Number)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.